Jeevan Scientific Technology Ltd

Jeevan Scientific Technology Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating despite recent market headwinds. This micro-cap healthcare services company’s price-to-earnings (P/E) ratio has plunged dramatically, signalling a potential opportunity for investors seeking value in a sector dominated by expensive peers.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Jeevan Scientific Technology Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling a potential opportunity for investors amid a mixed performance backdrop and evolving market dynamics.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 14 June 2026, providing investors with the latest insights into its performance and outlook.

Jeevan Scientific Technology Ltd, a micro-cap player in the healthcare services sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid mixed financial metrics and sector comparisons, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.

Jeevan Scientific Technology Ltd, a micro-cap player in the healthcare services sector, has recently experienced a notable shift in its valuation parameters, moving from a risky to a fair valuation grade. This article analyses the changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors amid recent market volatility.

Jeevan Scientific Technology Ltd has delivered a remarkable quarterly performance for March 2026, signalling a significant turnaround in its financial trajectory. The company’s latest results reveal robust revenue growth, substantial margin expansion, and a marked improvement in profitability, positioning it favourably within the healthcare services sector despite broader market headwinds.

Jeevan Scientific Technology Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Jeevan Scientific Technology Ltd., a micro-cap clinical research organisation, posted a consolidated net profit of ₹1.61 crores in Q4 FY26 (Mar'26), marking a 13.38% sequential improvement from ₹1.42 crores in Q3 FY26. However, this represents a sharp reversal from a loss of ₹1.30 crores in the same quarter last year, translating to a year-on-year decline of 223.85% when measured against the prior year's loss-making base.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of its performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the latest insights into its performance and outlook.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Surging past Rs 93.9 on 7 May 2026, Jeevan Scientific Technology Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally, driven by a confluence of robust technical indicators and sustained price momentum, underscores the stock’s impressive performance over the past year.

Surging past its previous peak, Jeevan Scientific Technology Ltd touched a fresh 52-week high of Rs 86.9 on 6 May 2026, marking a remarkable 108.84% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength across multiple timeframes.

Jeevan Scientific Technology Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the latest insights into its performance and outlook.